Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAT-2003 in Patients With Chylomicronemia
NCT02098278Phase 2Completed
- Sponsor
- Astria Therapeutics
- Start
- Mar 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules, Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of CAT-2003, sponsored by Astria Therapeutics. Started Mar 2014; status: completed.
02
Drugs
CAT-2003
Beyond the preview
Go deeper on NCT02098278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02098278.